Indian generic drugmaker settles lawsuit with Leo Pharma

Glenmark, an Indian developer of generic medicines, has agreed to a confidential settlement with Leo Pharma concerning a generic version of the Danish firm’s foam treatment for plaque psoriasis.
Photo: Leo Pharma/PR
Photo: Leo Pharma/PR
by ulrich quistgaard, translated by daniel pedersen

Leo Pharma’s lawsuit against Indian generic drugmaker Glenmark has concluded in a settlement, Leo Pharma informs MedWatch by email.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading